Clinical distinction of type 1 from type 2 diabetes mellitus.
Identification of individuals at risk of type 1 diabetes (including high-risk relatives of patients with diabetes).
Prediction of future need for insulin treatment in adult-onset diabetic patients.
< or = 0.02 nmol/L
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
4 days if negative; 9 days if positive
- Islet Cell Antibody
- Anti-IA2 Antibodies
Test sent to Mayo Medical Laboratories.